Lanean...

Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease

BACKGROUND: Ustekinumab and briakinumab are monoclonal antibodies that target the standard p40 subunit of cytokines interleukin‐12 and interleukin‐23 (IL‐12/23p40), which are involved in the pathogenesis of Crohn's disease (CD). A significant proportion of people with Crohn's disease fail...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Davies, Sarah C, Nguyen, Tran M, Parker, Claire E, MacDonald, John K, Jairath, Vipul, Khanna, Reena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2019
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6906134/
https://ncbi.nlm.nih.gov/pubmed/31828765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012804.pub2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!